Karen Haas to Antibody Formation
This is a "connection" page, showing publications Karen Haas has written about Antibody Formation.
Connection Strength
2.107
-
Phipps JP, Haas KM. An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses. J Infect Dis. 2019 01 07; 219(2):323-334.
Score: 0.673
-
McKay JT, Haro MA, Daly CA, Yammani RD, Pang B, Swords WE, Haas KM. PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism. J Immunol. 2017 09 15; 199(6):2020-2029.
Score: 0.609
-
Haas KM, Poe JC, Tedder TF. CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression. J Immunol. 2009 Sep 15; 183(6):3661-71.
Score: 0.351
-
Qin Q, Yin Z, Wu X, Haas KM, Huang X. Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers. Biomaterials. 2016 09; 101:189-98.
Score: 0.140
-
Yammani RD, Leyva MA, Jennings RN, Haas KM. C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. J Immunol. 2014 Dec 01; 193(11):5434-43.
Score: 0.126
-
Yammani RD, Haas KM. Primate B-1 cells generate antigen-specific B cell responses to T cell-independent type 2 antigens. J Immunol. 2013 Apr 01; 190(7):3100-8.
Score: 0.112
-
Lee Y, Haas KM, Gor DO, Ding X, Karp DR, Greenspan NS, Poe JC, Tedder TF. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement. J Immunol. 2005 Dec 15; 175(12):8011-23.
Score: 0.068
-
Bajer AA, Garcia-Tapia D, Jordan KR, Haas KM, Werling D, Howard CJ, Estes DM. Peripheral blood-derived bovine dendritic cells promote IgG1-restricted B cell responses in vitro. J Leukoc Biol. 2003 Jan; 73(1):100-6.
Score: 0.014
-
Davis WC, Konzek RL, Haas K, Estes DM, Hamilton MJ, Call DR, Apostolopoulos V, McKenzie IF. Use of the mannan receptor to selectively target vaccine antigens for processing and antigen presentation through the MHC class I and class II pathways. Ann N Y Acad Sci. 2002 Oct; 969:119-25.
Score: 0.014